Profilo
Paul F.
Engler is the founder of Cactus Feeders, Inc. which was founded in 1975, where he holds the title of Chairman.
Currently, he is a Director at Toragen, Inc. since 2022.
In the past, he worked as a Director at GlobeSecNine, Inc.
Posizioni attive di Paul F. Engler
| Società | Posizione | Inizio |
|---|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Fondatore | 01/01/1975 |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Direttore/Membro del Consiglio | 15/08/2022 |
Precedenti posizioni note di Paul F. Engler
| Società | Posizione | Fine |
|---|---|---|
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Cactus Feeders, Inc.
Cactus Feeders, Inc. Agricultural Commodities/MillingProcess Industries Provides cattle feeding services | Process Industries |
GlobeSecNine, Inc.
GlobeSecNine, Inc. Investment ManagersFinance GlobeSecNine invests in both public and private companies located in the United States. The firm targets companies operating in the fields of defense & classified services, port & transportation system security, agriculture, water and food safety sectors. The firm participates in MBOs, consolidations, build-ups and growth capital transactions. | Finance |
Toragen, Inc.
Toragen, Inc. BiotechnologyHealth Technology Engages in developing, repurposing and commercializing cancer drugs | Health Technology |
















